Prof Riccardo Dolcetti
Head, Translational and Clinical Immunotherapy
Department of Microbiology and Immunology
396 Scholarly works
9 Projects
HIGHLIGHTS
2026
Journal article
Control of poorly immunogenic tumors with systemic STING agonist-loaded liposomes targeting cross-presenting dendritic cells
DOI: 10.1002/cti2.701102026
Journal article
Abstract 7701: Potential clinical utility of small extracellular vesicles derived from head and neck tumors
DOI: 10.1158/1538-7445.am2026-77012026
Journal article
Potential clinical utility of small extracellular vesicles derived from head and neck tumours
DOI: 10.1002/VIW.202500812026
Journal article
Cover Picture: Potential clinical utility of small extracellular vesicles derived from head and neck tumours (View 1/2026)
DOI: 10.1002/viw2.701372025
Research grants (ARC, NHMRC, MRFF)
Off-the-Shelf Circular mRNA Vaccine Exploiting Non-Conventional Tumour Antigens to Improve Immunotherapy of Mismatch Repair-Proficient Colorectal Cancer
2023
Research grants (ARC, NHMRC, MRFF)
RNA Powered Antiviral Antibodies
2023
Research grants (other domestic)
Targeting Novel Classes of Tumour Antigens in BRCA-deficient Breast Cancer to Improve Immunotherapy Responses and Overcome Resistance
RECENT SCHOLARLY WORKS
2025
Journal article
Development of a circulating tumour cell culture model from head and neck squamous cell carcinoma
DOI: 10.1002/VIW.202500852025
Conference Proceedings
210. Development of novel immunotherapy-based therapies in oesophageal adenocarcinoma by harnessing tumour neoantigens
DOI: 10.1093/dote/doaf061.3142025
Journal article
Cryptic but critical: non-canonical antigens in cancer immunotherapy
DOI: 10.1016/j.it.2025.06.0022025
Journal article
Reduced HLA-I Transcript Levels and Increased Abundance of a CD56dim NK Cell Signature Are Associated with Improved Survival in Lower-Grade Gliomas
DOI: 10.3390/cancers170915702025
Journal article
CBL0137 and NKG2A blockade: a novel immuno-oncology combination therapy for Myc-overexpressing triple-negative breast cancers
DOI: 10.1038/s41388-024-03259-y2025
Journal article
Abstract A118: Targeting Replication Stress Promotes Anti-tumour Immune Responses that are Suppressed by Tumour-associated Myeloid cells
DOI: 10.1158/2326-6074.io2025-a118
RECENT PROJECTS
2025
Research grants (ARC, NHMRC, MRFF)
Advancing Differentiation Therapy and Immunotherapy for Paediatric High-Grade Gliomas Through Targeted Epigenome Regulation
2022
Research grants (other domestic)
New Strategies to Improve Personalized Immunotherapy of Breast Cancer.